AI assistant
PRECISION BIOSCIENCES INC — Director's Dealing 2025
Nov 4, 2025
34491_dirs_2025-11-04_5527e722-7309-4dd2-8781-6ca0f6979f6f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2025-11-02
Reporting Person: Amoroso Michael (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-11-02 | Common Stock | M | 9444 | — | Acquired | 118984 | Direct |
| 2025-11-03 | Common Stock | S | 3409 | $6.49 | Disposed | 115575 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-11-03 | Restricted Stock Units | $ | M | 9444 | Disposed | Common Stock (9444) | Direct |
Footnotes
F1: Represents the vesting and settlement of Restricted Stock Units ("RSUs") on November 2, 2025.
F2: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F3: The sales were effected pursuant to a Rule 10b5-1 plan adopted on August 2, 2024. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees.
F4: On November 2, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. The RSUs vested in full on November 2, 2025.